You are subscribed to the Drug Topics Hospital Pharmacists' Report.

Drug Topics Hospital Pharmacists' Report

eNewsletter Subscribe

Print Subscribe

Digital Edition Subscribe

July 24, 2014

Web Version  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

TODAY'S HEADLINES

Safer option for recurring pericarditis

Colchicine therapy, an effective anti-inflammatory agent for gout, is a promising treatment for preventing recurrent pericarditis. However, some patients have discontinued its use because of gastrointestinal intolerance, according to a report published online for the American Journal of Health-System Pharmacy. » More

FedEx indicted for assisting illegal pharmacies

First Google. Now FedEx. The shipping giant was recently indicted by a federal jury in San Francisco for "knowingly and intentionally" conspiring to distribute substances from unauthorized pharmacies. » More

CDC urges pharmacists to join anti-smoking campaign

The Centers for Disease Control and Prevention (CDC) recently launched a new webpage urging pharmacists to take a lead role in the government's smoking cessation efforts. » More

VIDEO: Better care at lower cost

Drug Topics Community Pharmacists' Report

That's the objective of many healthcare providers. Brian Isetts, a pharmacy professor at the University of Minnesota and a former policy fellow at CMS, addressed the topic at the PPSI Annual Breakfast Meeting in Orlando. » More

Continuing Education

MTM essentials for antiplatelet therapy in cardiovascular disease

This month's article is the sixth in a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to review the pharmacokinetic and pharmacodynamic differences, clinical indications, and pertinent drug-drug interactions for antiplatelet agents in cardiovascular disease.

To read and print the article with TEST QUESTIONS, click here.To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the session code 14DT08-KTF27.

Announcement: Starting this month, our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/.

 

Check these out, too

Residency, technician programs increasing

Niacin combo poses risks to heart patients

HIT and medication adherence

High-alert medication list updated

Voices

Anticoagulation Update

JP at Large

View from the Zoo

Viewpoints

Regulatory and Legal

Meetings and Events

 
Powered by Modern Medicine Advanstar Medical Communications Group